GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (LTS:0QCO) » Definitions » PB Ratio

Pharming Group (LTS:0QCO) PB Ratio : 2.76 (As of Apr. 01, 2025)


View and export this data going back to 2007. Start your Free Trial

What is Pharming Group PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-04-01), Pharming Group's share price is €0.783. Pharming Group's Book Value per Share for the quarter that ended in Dec. 2024 was €0.28. Hence, Pharming Group's PB Ratio of today is 2.76.

The historical rank and industry rank for Pharming Group's PB Ratio or its related term are showing as below:

LTS:0QCO' s PB Ratio Range Over the Past 10 Years
Min: 2.16   Med: 4.53   Max: 99.31
Current: 2.74

During the past 13 years, Pharming Group's highest PB Ratio was 99.31. The lowest was 2.16. And the median was 4.53.

LTS:0QCO's PB Ratio is ranked worse than
57.3% of 1274 companies
in the Biotechnology industry
Industry Median: 2.29 vs LTS:0QCO: 2.74

During the past 12 months, Pharming Group's average Book Value Per Share Growth Rate was 3.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 5.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 11.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 24.30% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Pharming Group was 103.50% per year. The lowest was -60.80% per year. And the median was 8.20% per year.

Back to Basics: PB Ratio


Pharming Group PB Ratio Historical Data

The historical data trend for Pharming Group's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharming Group PB Ratio Chart

Pharming Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.40 2.95 3.73 3.48 2.99

Pharming Group Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.48 3.63 2.48 2.52 3.24

Competitive Comparison of Pharming Group's PB Ratio

For the Biotechnology subindustry, Pharming Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharming Group's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharming Group's PB Ratio distribution charts can be found below:

* The bar in red indicates where Pharming Group's PB Ratio falls into.


;
;

Pharming Group PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Pharming Group's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2024)
=0.783/0.284
=2.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Pharming Group  (LTS:0QCO) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Pharming Group PB Ratio Related Terms

Thank you for viewing the detailed overview of Pharming Group's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharming Group Business Description

Address
Darwinweg 24, Leiden, ZH, NLD, 2333 CR
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

Pharming Group Headlines

No Headlines